Latest Articles
-
Is Qualcomm Stock’s 24% Drop A Bargain?
Qualcomm (QCOM) stock has fallen by 24.5% in less than a month, from $181.87 on 8th Jan, 2026 to $137.34 now. Should you buy this dip? Dip buying is a viable strategy for quality stocks that have a history of recovering from dips. As it turns ou...
-
Abercrombie & Fitch Stock To $127?
Abercrombie & Fitch (ANF) stock has fallen by 24.8% in less than a month, from $129.85 on 8th Jan, 2026 to $97.66 now. What comes next? We believe there is a good chance of a stock rebound considering history of recovery post-dips and our cu...
-
Stocks, Bonds, Gold, Crypto: Market Update 2/6/2026
Here is a quick snapshot of how different asset classes moved yesterday, last week, and the last month. Equity rose 1.9% yesterday, versus -0.2% weekly and 0.2% monthly changes. Bonds increased 0.06% yesterday, after 0% weekly and 0.01% monthl...
-
Can Oracle Stock Recover If Markets Fall?
Oracle (ORCL) stock is down 13.2% in 5 trading days. The recent slide reflects renewed concerns around Oracle’s AI infrastructure debt, bondholder lawsuits, and AI’s impact on core software, but sharp drops like this often raise a tou...
-
With Zillow Stock Sliding, Have You Assessed The Risk?
Zillow (Z) stock is down 19.4% in 21 trading days. The recent slide reflects renewed concerns around broader real estate market challenges and revenue concerns, but sharp drops like this often raise a tougher question: is the weakness temporary, ...
-
With Molina Healthcare Stock Sliding, Have You Assessed The Risk?
Molina Healthcare (MOH) stock is down 25.5% in a day. The recent slide reflects renewed concerns around Molina Healthcare’s Q4 loss, weak 2026 outlook, and rising medical costs in Medicaid, but sharp drops like this often raise a tougher qu...
-
Can Intuitive Surgical Stock Recover If Markets Fall?
Intuitive Surgical (ISRG) stock is down 17.6% in 21 trading days. The recent slide reflects renewed concerns around slowing da Vinci procedure growth and institutional selling, but sharp drops like this often raise a tougher question: is the weak...
-
Is Impinj Stock Built to Withstand More Downside?
Impinj (PI) stock is down 24.6% in a day. The recent slide reflects renewed concerns around Impinj’s weak Q1 2026 forecast due to inventory reductions in retail/logistics and project delays, but sharp drops like this often raise a tougher q...
-
Anthropic’s Big Software Reset: Winners & Losers
In early February 2026, the tech sector saw a sharp and sudden valuation reset, with nearly $300 billion in market capitalization wiped out in roughly a single trading day. The declines were concentrated in software, data services, and IT outsour...
-
A Money Making Strategy for Qualcomm’s Memory Crisis
Qualcomm (QCOM) shares plunged nearly 9% on February 5, 2026 to $136 because of a dramatic shortfall in forward guidance. The core issue is a global DRAM shortage and surging memory prices, driven by high demand for AI data centers, which has for...
-
McKesson Stock’s 17% Earnings Rip: Is The “Boring” Distributor Dead?
On Wednesday, McKesson (MCK) shattered its “boring middleman” reputation. The stock jumped 17% to a new all-time high of $958 on volume nearly 6x the daily average. This wasn’t just a short squeeze. It was a structural re-rating...
-
Should Estee Lauder Stock Investors Panic?
The beauty industry was jolted yesterday as shares of Estée Lauder (EL) plummeted nearly 20%, following the Q2 FY26 earnings release. While the company reported a beat on headline earnings and revenue, the forward-looking commentary painted a s...
-
This Strategy Pays You 10.0% While Lining Up LRCX at Bargain Prices
At about $213.31 a share, Lam Research (LRCX) is trading about 14% below its 52-week high. Do you think LRCX stock is a good long-term bet at current levels? What about at a 40% discount at about $128 per share? If you think that is a steal and ...
-
Catalysts That Could Propel UnitedHealth Stock to the Moon
UnitedHealth has demonstrated significant rally potential, with multiple instances of >30% gains in under two months recorded in key years 2010, 2019, 2020, 2021, and 2025. Notably, it achieved >50% rallies twice in 2020 and 2025. If past p...
-
What Could Go Wrong With Intel Stock?
Intel (INTC) has stumbled before. Its stock has plunged more than 30% within a span of less than 2 months on 3 occasions in recent years, wiping out billions in market value and erasing massive gains in a single correction. If history is any guid...
